In an editorial posted yesterday on the Coalition for Healthcare Communication website, Coalition Executive Director John Kamp states that the FDA's recent report on the past year's drug approvals demonstrates that "despite rumors to the contrary, medical innovation is not dead." However, Kamp cautions that for progress to continue, a "clean" Prescription Drug User Fee Act bill must be passed and that industry/government collaborations should be encouraged. Read more.

Full Story:

Related Summaries